Xinxin Gan

1.1k total citations
35 papers, 782 citations indexed

About

Xinxin Gan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xinxin Gan has authored 35 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Xinxin Gan's work include Renal cell carcinoma treatment (10 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related molecular mechanisms research (4 papers). Xinxin Gan is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related molecular mechanisms research (4 papers). Xinxin Gan collaborates with scholars based in China, Spain and United States. Xinxin Gan's co-authors include Anbang Wang, Linhui Wang, Yi Bao, Zhenjie Wu, Tangliang Zhao, Qiong Chen, Li Zhou, Naijun Miao, Linhui Wang and Limin Lü and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Metabolism and Scientific Reports.

In The Last Decade

Xinxin Gan

33 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxin Gan China 16 481 306 182 98 64 35 782
Pengyuan Liu China 17 760 1.6× 411 1.3× 116 0.6× 186 1.9× 58 0.9× 41 1.1k
Yoo Hyung Kim South Korea 11 470 1.0× 195 0.6× 93 0.5× 134 1.4× 90 1.4× 22 935
Qiuxia Cui China 17 414 0.9× 213 0.7× 190 1.0× 153 1.6× 26 0.4× 38 807
Xinzhe Chen China 17 701 1.5× 466 1.5× 116 0.6× 82 0.8× 20 0.3× 40 931
Guokun Wang China 17 570 1.2× 428 1.4× 144 0.8× 79 0.8× 16 0.3× 36 848
Yuzhu Li China 9 334 0.7× 263 0.9× 438 2.4× 87 0.9× 21 0.3× 28 749
Heli Xiang China 12 319 0.7× 223 0.7× 152 0.8× 78 0.8× 76 1.2× 36 716
Z Liu China 10 395 0.8× 222 0.7× 59 0.3× 157 1.6× 44 0.7× 25 717
Chunhua Weng China 15 388 0.8× 173 0.6× 69 0.4× 65 0.7× 139 2.2× 24 668

Countries citing papers authored by Xinxin Gan

Since Specialization
Citations

This map shows the geographic impact of Xinxin Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Gan more than expected).

Fields of papers citing papers by Xinxin Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxin Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Gan. The network helps show where Xinxin Gan may publish in the future.

Co-authorship network of co-authors of Xinxin Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxin Gan. A scholar is included among the top collaborators of Xinxin Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxin Gan. Xinxin Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gan, Xinxin, et al.. (2024). A Mendelian randomization study on causal effects of leisure sedentary behavior on the risk of erectile dysfunction. Andrology. 12(8). 1841–1850. 3 indexed citations
3.
Gan, Xinxin, Rui Yan, Zheng Wang, et al.. (2024). LDHA‐mediated M2‐type macrophage polarization via tumor‐derived exosomal EPHA2 promotes renal cell carcinoma progression. Molecular Carcinogenesis. 63(8). 1486–1499. 11 indexed citations
4.
Gan, Xinxin, et al.. (2024). Research progress of the Hippo signaling pathway in renal cell carcinoma. Asian journal of urology. 11(4). 511–520. 5 indexed citations
5.
Jiang, Aimin, Zi‐jun Xu, Xiao Fang, et al.. (2023). RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations
6.
Wang, Zheng, Yunyun Wang, Jiachao Xiong, et al.. (2023). Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 10. 1121340–1121340. 7 indexed citations
7.
Shi, Xiaolei, Aimin Jiang, Haoqing Shi, et al.. (2023). Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus. Scientific Reports. 13(1). 9778–9778. 4 indexed citations
8.
Ko, Andrew H., Kyu‐pyo Kim, Jens T. Siveke, et al.. (2023). Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. The Oncologist. 28(6). 553–e472. 37 indexed citations
9.
Niu, Liwei, et al.. (2023). Improved Model for Smoke Detection Based on Concentration Features using YOLOv7tiny. International Journal of Advanced Computer Science and Applications. 14(9). 1 indexed citations
10.
Luo, Yuxiang, Xiaoxiao Liu, Xiaojing Lu, et al.. (2023). Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Journal for ImmunoTherapy of Cancer. 11(12). e007678–e007678. 8 indexed citations
11.
Jiang, Aimin, Ye Zhou, Wenliang Gong, et al.. (2022). CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative Medicine and Cellular Longevity. 2022(1). 5910575–5910575. 38 indexed citations
12.
Jiang, Aimin, Anbang Wang, Wenliang Gong, et al.. (2022). Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 3617775–3617775. 14 indexed citations
13.
Wei, Gang, Honglin Sun, Kai Dong, et al.. (2021). The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metabolism. 33(10). 2021–2039.e8. 71 indexed citations
14.
15.
Wang, Anbang, Aimin Jiang, Xinxin Gan, et al.. (2020). EGFR‐AS1 Promotes Bladder Cancer Progression by Upregulating EGFR. BioMed Research International. 2020(1). 6665974–6665974. 18 indexed citations
16.
Zhao, Tangliang, Yi Bao, Xinxin Gan, et al.. (2019). DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma. Theranostics. 9(21). 6175–6190. 41 indexed citations
17.
Chen, Qiong, Tao Liu, Yi Bao, et al.. (2019). CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Letters. 469. 68–77. 150 indexed citations
18.
Zhao, Tangliang, Xiaolong Liang, Junming Chen, et al.. (2019). ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation. Biochemical and Biophysical Research Communications. 516(3). 880–887. 17 indexed citations
19.
Shen, Yang, Naijun Miao, Bao Wang, et al.. (2017). c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling. Kidney International. 92(4). 888–899. 51 indexed citations
20.
Shen, Yang, Naijun Miao, Xinxin Gan, et al.. (2016). N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys. Acta Pharmacologica Sinica. 37(5). 637–644. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pengyuan Liu Breakdown of academic impact, for papers by Yoo Hyung Kim Breakdown of academic impact, for papers by Qiuxia Cui Breakdown of academic impact, for papers by Xinzhe Chen Breakdown of academic impact, for papers by Guokun Wang Breakdown of academic impact, for papers by Yuzhu Li Breakdown of academic impact, for papers by Heli Xiang Breakdown of academic impact, for papers by Z Liu Breakdown of academic impact, for papers by Chunhua Weng
Rankless by CCL
2026